acetaminophen has been researched along with allopurinol in 42 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (14.29) | 18.7374 |
1990's | 2 (4.76) | 18.2507 |
2000's | 18 (42.86) | 29.6817 |
2010's | 16 (38.10) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duffy, EM; Jorgensen, WL | 1 |
Topliss, JG; Yoshida, F | 1 |
Abraham, MH; Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Dybing, E | 1 |
Johnson, GF; Kiser, EJ; Witte, DL | 1 |
Feldman, S; Kramer, WG | 1 |
Jaeschke, H | 1 |
Nelson, SD; Tirmenstein, MA | 1 |
Dubbelman, TM; Koster, JF; Van Steveninck, J | 1 |
Gale, GR; Smith, AB | 1 |
Asamoto, M; Fukushima, S; Hagiwara, A; Kurata, Y; Masui, T | 1 |
Huang, PC; Lin, CC | 1 |
Hanioka, K; Hojo, M; Miyata, M; Yamazoe, Y | 1 |
Jaeschke, H; Knight, TR | 1 |
Fujino, Y; Ku, Y; Kuroda, Y; Li, S; Suzuki, Y; Takahashi, T; Tanioka, Y; Tsujimura, T; Yoshida, I | 1 |
Price, SL | 1 |
Ali, S; Pawa, S | 1 |
Andrade, P; Brinca, A; Gonçalo, M | 1 |
Borchers, S; Findeisen, R; Krauss, M; Kuepfer, L; Lippert, J; Schaller, S | 1 |
Bajt, ML; Jaeschke, H; Lebofsky, M; McGill, MR; Williams, CD | 1 |
Kim, SR; Koh, BS; Lee, JH; Leem, DW; Moon, IJ; Park, HJ; Park, JW; Park, KH | 1 |
Marks, DJ; Stimpson, PJ | 1 |
Asprodini, EK; Begas, E; Kilindris, T; Kouretas, D; Kouvaras, E; Tsioutsioumi, A | 1 |
Nakamura, R; Saito, Y | 1 |
3 review(s) available for acetaminophen and allopurinol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The computational prediction of pharmaceutical crystal structures and polymorphism.
Topics: Acetaminophen; Allopurinol; Aspirin; Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Computer Simulation; Crystallography; Databases, Factual; Diflunisal; Hormones; Humans; Hydrogen Bonding; Kinetics; Models, Molecular; Molecular Conformation; Molecular Structure; Pharmaceutical Preparations; Phase Transition; Software; Static Electricity; Technology, Pharmaceutical; Thermodynamics | 2004 |
[Mechanisms of Severe Cutaneous Adverse Reactions and a New Treatment Strategy].
Topics: Acetaminophen; Adrenal Cortex Hormones; Allopurinol; Antigens, Differentiation, T-Lymphocyte; Carbamazepine; CD8-Positive T-Lymphocytes; Cyclosporine; Epidermis; Etanercept; Fas Ligand Protein; HLA Antigens; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Japan; Lamotrigine; Plasma Exchange; Stevens-Johnson Syndrome; Tumor Necrosis Factor-alpha | 2019 |
39 other study(ies) available for acetaminophen and allopurinol
Article | Year |
---|---|
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogPoct: a tool for lipophilicity determination in drug discovery.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Solvents | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Methyldopa binding to cells in culture.
Topics: Acetaminophen; Allopurinol; Animals; Ascorbic Acid; Carcinoma, Hepatocellular; Cells, Cultured; Deferoxamine; Dimethylnitrosamine; Edetic Acid; Furosemide; Glutathione; Liver Neoplasms; Maleates; Methyldopa; Neoplasms, Experimental; Protein Binding; Rats; Superoxide Dismutase; Time Factors; Xanthines | 1977 |
Serum uric acid determined by reversed-phase liquid chromatography with spectrophotometric detection.
Topics: Acetaminophen; Allopurinol; Chromatography, Liquid; Drug Interactions; Humans; Methods; Oxypurinol; Salicylates; Spectrophotometry, Ultraviolet; Theophylline; Urate Oxidase; Uric Acid | 1978 |
High-performance liquid chromatographic assay for allopurinol and oxipurinol in human plasma.
Topics: Acetaminophen; Allopurinol; Chromatography, High Pressure Liquid; Humans; Methods; Oxypurinol; Pyrimidines | 1979 |
Glutathione disulfide formation and oxidant stress during acetaminophen-induced hepatotoxicity in mice in vivo: the protective effect of allopurinol.
Topics: Acetaminophen; Adenosine Triphosphate; Alanine Transaminase; Allopurinol; Animals; Chemical and Drug Induced Liver Injury; Liver; Liver Diseases; Male; Mice; Mice, Inbred Strains; Oxidation-Reduction; Oxygen; Xanthine Dehydrogenase; Xanthine Oxidase | 1990 |
Acetaminophen-induced oxidation of protein thiols. Contribution of impaired thiol-metabolizing enzymes and the breakdown of adenine nucleotides.
Topics: Acetaminophen; Acetanilides; Adenine Nucleotides; Analgesics; Animals; Cytosol; Glutathione Peroxidase; Kinetics; Liver; Male; Mice; Oxidation-Reduction; Proteins; Reference Values; Sulfhydryl Compounds; Sulfurtransferases; Xanthine Dehydrogenase; Xanthine Oxidase | 1990 |
Xanthine oxidase-catalysed oxidation of paracetamol.
Topics: Acetaminophen; Catalysis; Horseradish Peroxidase; Hydroxides; Polymers; Xanthine Oxidase | 1989 |
Interaction of caffeine with acetaminophen in mice: schedule dependency of the antagonism by caffeine of acetaminophen hepatotoxicity and the effects of caffeine metabolites, allopurinol, and diethyl ether.
Topics: Acetaminophen; Alanine Transaminase; Allopurinol; Animals; Biotransformation; Caffeine; Ethanol; Ether; Ethyl Ethers; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA | 1988 |
Promoting effects of various agents in rat urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Topics: Acetaminophen; Allopurinol; Aminocaproates; Animals; Biphenyl Compounds; Butylhydroxybutylnitrosamine; Cocarcinogenesis; Hydrogen-Ion Concentration; Indomethacin; Male; Nitrosamines; Rats; Rats, Inbred F344; Sodium; Urinary Bladder; Urinary Bladder Calculi; Urinary Bladder Neoplasms | 1986 |
Antioxidant and hepatoprotective effects of Acathopanax senticosus.
Topics: Acetaminophen; Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Drugs, Chinese Herbal; Free Radical Scavengers; Lipid Peroxidation; Liver; Male; Medicine, Chinese Traditional; Plant Extracts; Plant Roots; Rats; Rats, Wistar; Taiwan; Xanthine Oxidase | 2000 |
Hepatotoxicity of acetaminophen and N-acetyl-p-benzoquinone imine and enhancement by fructose.
Topics: Acetaminophen; Alanine Transaminase; Allopurinol; Animals; Benzoquinones; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Drug Synergism; Enzyme Inhibitors; Fructose; Glucose; Imines; L-Iditol 2-Dehydrogenase; L-Lactate Dehydrogenase; Liver; Liver Diseases; Male; Portal Vein; Rats; Rats, Sprague-Dawley; Sucrose; Xanthine Oxidase | 2000 |
Acetaminophen-induced inhibition of Fas receptor-mediated liver cell apoptosis: mitochondrial dysfunction versus glutathione depletion.
Topics: Acetaminophen; Allopurinol; Animals; Antibodies, Antinuclear; Apoptosis; Caspase 3; Caspases; Drug Therapy, Combination; fas Receptor; Glutathione; Hepatocytes; In Situ Nick-End Labeling; Liver; Male; Mice; Mice, Inbred C3H; Mitochondria | 2002 |
Successful 24-h preservation of canine small bowel using the cavitary two-layer (University of Wisconsin solution/perfluorochemical) cold storage method.
Topics: Acetaminophen; Adenosine; Allopurinol; Animals; Blood Glucose; Cold Temperature; Dogs; Fluorocarbons; Glutathione; Insulin; Intestine, Small; Organ Preservation; Organ Preservation Solutions; Raffinose | 2002 |
Liver necrosis and fulminant hepatic failure in rats: protection by oxyanionic form of tungsten.
Topics: Acetaminophen; Alkaline Phosphatase; Allopurinol; Animals; Bromobenzenes; Carbon Tetrachloride Poisoning; Chloroform; Dimethyl Sulfoxide; Female; Lethal Dose 50; Liver; Liver Failure; Necrosis; Oxidative Stress; Rats; Rats, Wistar; Thioacetamide; Transaminases; Tungsten Compounds | 2004 |
Patch testing in fixed drug eruptions--a 20-year review.
Topics: Acetaminophen; Adult; Aged; Allopurinol; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antipyretics; Cetirizine; Cross Reactions; Drug Eruptions; Female; Gout Suppressants; Histamine Antagonists; Humans; Male; Middle Aged; Patch Tests; Retrospective Studies; Sensitivity and Specificity | 2011 |
Integrating cellular metabolism into a multiscale whole-body model.
Topics: Acetaminophen; Allopurinol; Ammonia; Chemical and Drug Induced Liver Injury; Computational Biology; Computer Simulation; Hepatocytes; Humans; Hyperuricemia; Inactivation, Metabolic; Liver; Metabolism; Models, Biological; Urea; Urea Cycle Disorders, Inborn; Uric Acid | 2012 |
Protection against acetaminophen-induced liver injury by allopurinol is dependent on aldehyde oxidase-mediated liver preconditioning.
Topics: Acetaminophen; Aldehyde Oxidase; Allopurinol; Animals; Chemical and Drug Induced Liver Injury; Cysteine; Drug Overdose; Glutathione; JNK Mitogen-Activated Protein Kinases; Liver; Male; Metallothionein; Mice; Mice, Inbred C3H; Mitochondria; Oxypurinol; Phosphorylation; Xanthine Oxidase | 2014 |
Clinical features of and genetic predisposition to drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a single Korean tertiary institution patients-investigating the relation between the HLA -B*4403 allele and lamotrigine.
Topics: Acetaminophen; Acetazolamide; Adult; Aged; Aged, 80 and over; Alleles; Allopurinol; Anti-Bacterial Agents; Anticonvulsants; Asian People; Female; Genetic Predisposition to Disease; HLA-B Antigens; Humans; Lamotrigine; Male; Middle Aged; Plants, Medicinal; Republic of Korea; Stevens-Johnson Syndrome; Tertiary Care Centers; Triazines; Young Adult | 2015 |
Leading articles in medical journals in 1966.
Topics: Abortion, Induced; Acetaminophen; Adrenocortical Adenoma; Allopurinol; Analgesics; Antineoplastic Agents; Attitude of Health Personnel; Attitude to Health; Bird Fancier's Lung; Celiac Disease; Chemical and Drug Induced Liver Injury; Dermatitis Herpetiformis; Drug Discovery; Gout; Gout Suppressants; Graft Rejection; Granulomatous Disease, Chronic; History, 20th Century; Humans; Medicare; Periodicals as Topic; Publishing; United Kingdom; United States | 2016 |
Dietary effects of Sideritis scardica "mountain tea" on human in vivo activities of xenobiotic metabolizing enzymes in healthy subjects.
Topics: Acetaminophen; Adult; Arylamine N-Acetyltransferase; Caffeine; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2A6; Dietary Exposure; Female; Glucuronosyltransferase; Healthy Volunteers; Herb-Drug Interactions; Humans; Male; Middle Aged; Plant Components, Aerial; Saliva; Sideritis; Substrate Specificity; Teas, Herbal; Xanthine Oxidase; Xenobiotics; Young Adult | 2018 |